Protocol description of the HOVON 141/VISION trial: a prospective, multicentre, randomised phase II trial of ibrutinib plus venetoclax in patients with creatinine clearance ≥30 mL/min who have relapsed or refractory chronic lymphocytic leukaemia (RR-CLL) with or without TP53 aberrations
Levin, Mark-David, Kater, Arnon, Mattsson, Mattias, Kersting, Sabina, Ranti, Juha, Thi Tuyet Tran, Hoa, Nasserinejad, Kazem, Niemann, Carsten Utoft
Published in BMJ open (15.10.2020)
Published in BMJ open (15.10.2020)
Get full text
Journal Article
Characterization of real‐world treatment practices and outcomes among patients with chronic lymphocytic leukemia treated in a Finnish tertiary center
Ranti, Juha, Perkonoja, Katariina, Kauko, Tommi, Loponen, Heidi, Joensuu, Emmi I., Järvinen, Tiina M.
Published in EJHaem (01.02.2022)
Published in EJHaem (01.02.2022)
Get full text
Journal Article
S148: TIME‐LIMITED VENETOCLAX AND IBRUTINIB FOR PATIENTS WITH RELAPSED/REFRACTORY CLL WHO HAVE UNDETECTABLE MRD – 4‐YEAR FOLLOW UP FROM THE RANDOMIZED PHASE II VISION/HO141 TRIAL
Kater, Arnon, Dubois, Julie, Brieghel, Christian, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit, Mous, Rogier, Mellink, Clemens, Dobber, Johan, Poulsen, Christian, Da Cunha‐Bang, Caspar, Fredriksen, Hendrik, Janssens, Ann, Schjodt, Ida, Dompeling, Ellen, Ranti, Juha, Mattsson, Mattias, Bellido, Mar, Tran, Hoa, Nasserinejad, Kazem, Levin, Mark‐David, Niemann, Carsten
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
S144: BTK AND BCL‐2 ACTIVITY AT BASELINE PREDICTS MRD STATUS FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB + VENETOCLAX IN THE HOVON 141/VISION TRIAL
Urban, Aleksandra, Hermansen, Johanne, Yin, Yanping, Kong, Weikaixin, Teglgaard, Rebecca, Brieghel, Christian, Kersting, Sabina, Tjønnfjord, Geir E., Levin, Mark‐David, Tran, Hoa T. T., Mattsson, Mattias, Ranti, Juha, Veldhuis, Gerrit‐Jan, Da Cunha‐Bang, Caspar, Mous, Rogier, Dubois, Julie, Kater, Arnon, Niemann, Carsten, Aittokallio, Tero, Skånland, Sigrid
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Clinical and healthcare burden of disease associated with cytomegalovirus in allogeneic hematopoietic stem cell transplantation – A retrospective single‐center study
Ranti, Juha, Perkonoja, Katariina, Kauko, Tommi, Korhonen, Riku
Published in Transplant infectious disease (01.12.2022)
Published in Transplant infectious disease (01.12.2022)
Get full text
Journal Article
Treatment and clinical outcomes of patients with acute myeloid leukemia in Finland 2010–2020: A retrospective analysis of electronic health records
Ranti, Juha, Pudas, Hanna, Ranta, Martta, Tuominen, Samuli, Uusi‐Rauva, Kristiina, Lammela, Johanna
Published in European journal of haematology (29.07.2024)
Published in European journal of haematology (29.07.2024)
Get full text
Journal Article
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy
Feuth, Eeva, Nieminen, Valtteri, Palomäki, Antti, Ranti, Juha, Sucksdorff, Marcus, Finnilä, Taru, Oksi, Jarmo, Vuorinen, Tytti, Feuth, Thijs
Published in European journal of clinical microbiology & infectious diseases (01.04.2024)
Published in European journal of clinical microbiology & infectious diseases (01.04.2024)
Get full text
Journal Article
Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial
Kater, Arnon P, Levin, Mark-David, Dubois, Julie, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit J, Mous, Rogier, Mellink, Clemens H M, van der Kevie-Kersemaekers, Anne-Marie F, Dobber, Johan A, Poulsen, Christian B, Frederiksen, Henrik, Janssens, Ann, Schjødt, Ida, Dompeling, Ellen C, Ranti, Juha, Brieghel, Christian, Mattsson, Mattias, Bellido, Mar, Tran, Hoa T T, Nasserinejad, Kazem, Niemann, Carsten U
Published in The lancet oncology (01.06.2022)
Published in The lancet oncology (01.06.2022)
Get full text
Journal Article
Early CD8.sup.+-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT
Ranti, Juha, Kurki, Samu, Salmenniemi, Urpu, Putkonen, Mervi, Salomäki, Soile, Itälä-Remes, Maija
Published in PloS one (20.09.2018)
Published in PloS one (20.09.2018)
Get full text
Journal Article
Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia
Niemann, Carsten U., Levin, Mark-David, Dubois, Julie, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit J., Mous, Rogier, Mellink, Clemens H.M., Dobber, Johan A., Poulsen, Christian B., Frederiksen, Henrik, Janssens, Ann, Schjødt, Ida, Dompeling, Ellen C., Ranti, Juha, Mattsson, Mattias, Bellido, Mar, Tran, Hoa T.T., Nasserinejad, Kazem, Kater, Arnon P.
Published in Blood (25.02.2021)
Published in Blood (25.02.2021)
Get full text
Journal Article
Time-Limited Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Who Have Undetectable MRD - Primary Analysis from the Randomized Phase II Vision HO141 Trial
Niemann, Carsten Utoft, Dubois, Julie, Brieghel, Christian, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit J, Mous, Rogier, Mellink, Clemens, Dobber, Johan A, Poulsen, Christian Bjørn, Frederiksen, Henrik, Janssens, Ann, Schjødt, Ida, Dompeling, Ellen C, Ranti, Juha, Mattsson, Mattias, Bellido, Mar, Nasserinejad, Kazem, Tran, Hoa Thi Tuyet, Levin, Mark-David, Kater, Arnon P.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) - 15-Month Safety, Response and MRD Evaluation: Third Interim Analysis from the Phase II Vision HO141 Trial
Niemann, Carsten Utoft, Dubois, Julie, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit J, Mous, Rogier, Mellink, Clemens, Dobber, Johan A, Poulsen, Christian Bjørn, Frederiksen, Henrik, Janssens, Ann, Schjødt, Ida, Dompeling, Ellen C, Ranti, Juha, Mattsson, Mattias, Bellido, Mar, Tran, Hoa T, Nasserinejad, Kazem, Levin, Mark-David, Kater, Arnon P.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article